Several medications effectively treat OCD, with a specific class of antidepressants called SSRIs serving as the primary option. Five medications currently have FDA approval for OCD: fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), and clomipramine (Anafranil). These aren’t the only options, though. When first-line treatments fall short, doctors have additional strategies that can make a meaningful difference.
SSRIs: The Standard Starting Point
SSRIs are the go-to medication for OCD because they boost serotonin activity in the brain. In OCD, a circuit connecting the front of the brain, a deep structure called the caudate nucleus, and the thalamus runs hotter than normal. Brain imaging studies show increased metabolic activity in these regions, and successful treatment, whether with medication or therapy, brings that activity back to normal levels. SSRIs help by increasing serotonin signaling in this overactive loop.
One important distinction: OCD typically requires higher doses than depression or anxiety. The doses that work for OCD are often two to three times what’s used for those other conditions. For fluoxetine or paroxetine, effective OCD treatment usually requires at least 40 to 60 mg per day. For sertraline or fluvoxamine, that range is 200 to 300 mg per day. Some patients benefit from going even higher. In specialized OCD clinics, it’s not unusual for sertraline doses to reach well above the standard 200 mg ceiling, sometimes up to the equivalent of 400 to 650 mg when factoring in combined strategies.
If your doctor started you on a low dose and you’re not feeling better yet, that’s expected. The dose often needs to climb before you’ll notice real improvement.
How Long Before They Work
OCD medications take longer to kick in than most people expect. A meta-analysis found that SSRIs show a statistically measurable benefit over placebo within two weeks, but this early improvement is modest. Clinical guidelines recommend sticking with an SSRI for at least 10 to 12 weeks before deciding it isn’t working, with at least six of those weeks at the higher doses OCD requires.
This is a genuinely difficult waiting period. You may spend two or three months on a medication before knowing whether it’s the right one. If the first SSRI doesn’t help enough, trying a different one is standard practice, since people respond differently to each. But each trial means another 8 to 12 weeks of patience.
Clomipramine: An Older but Powerful Option
Clomipramine is the one FDA-approved OCD medication that isn’t an SSRI. It’s a tricyclic antidepressant that affects serotonin strongly but also hits other chemical systems in the brain. Some patients who don’t respond to SSRIs do respond to clomipramine, and some evidence suggests it may be slightly more potent for OCD symptoms overall.
The trade-off is side effects. Because clomipramine is less targeted than SSRIs, it’s more likely to cause dry mouth, constipation, dizziness when standing up, blurred vision, drowsiness, and weight gain. Some people also experience muscle stiffness, tingling sensations, or difficulty urinating. These effects make it harder to tolerate than SSRIs for many people, which is why doctors usually try SSRIs first. But for those who can manage the side effects, clomipramine remains a valuable tool.
When the First Medication Isn’t Enough
Roughly 40 to 60 percent of people with OCD don’t get adequate relief from their first SSRI alone. For treatment-resistant cases, adding a low dose of an antipsychotic medication to the existing SSRI is the most studied augmentation strategy. A meta-analysis of 12 controlled trials found that about one-third of patients with treatment-resistant OCD improved when an antipsychotic was added. Specifically, 28% of patients in the augmentation group met the threshold for meaningful improvement (a 35% or greater reduction in symptoms), compared to 13% on placebo.
Among the antipsychotics studied, risperidone had the strongest evidence. It was the only one that consistently outperformed placebo across multiple trials, with a large effect size. Quetiapine, aripiprazole, and olanzapine have also been studied, but their individual results were less convincing when analyzed rigorously. Despite that, doctors still try different options since individual responses vary.
Newer Approaches for Difficult Cases
Research is exploring medications that target glutamate, a different brain chemical than serotonin. In a small but well-designed crossover trial, a single intravenous infusion of ketamine produced rapid OCD symptom relief. Half the participants met criteria for treatment response, compared to none who received a placebo infusion, and the effects lasted up to seven days. The effect sizes were large.
These results are promising but preliminary. The trial included only 15 participants, and ketamine isn’t a practical long-term solution in its current form. Other glutamate-targeting medications are being explored as more accessible alternatives, but none have become part of standard OCD treatment yet.
OCD Medications for Children
Sertraline and fluvoxamine have FDA labeling for treating pediatric OCD, and both have been studied in children using flexible dose ranges of 50 to 200 mg per day. Fluoxetine has also been studied in younger patients, with children under 12 averaging about 35 mg per day and adolescents averaging around 64 mg per day. Clomipramine has been studied in children as well, though its side effect profile makes SSRIs the preferred first choice for younger patients. Dosing in children is typically weight-based, usually falling in the range of 1 to 3 mg per kilogram per day for sertraline and fluvoxamine.
How Long You’ll Stay on Medication
OCD is a condition that tends to come back when medication is stopped, especially if it’s stopped too soon. Treatment guidelines recommend continuing medication for one to two years after your symptoms have stabilized. A 2025 meta-analysis confirmed why: patients who discontinued their antidepressant had significantly higher relapse rates than those who stayed on it. Continuing medication cut the risk of relapse roughly in half, and for every five patients who stayed on their medication, one avoided a relapse that would have occurred otherwise.
This doesn’t mean medication is forever for everyone. But stopping should be a gradual, planned process rather than something done once you feel better. Combining medication with a specific form of therapy called exposure and response prevention gives you the best odds of maintaining your gains if you eventually taper off. Many people, however, choose to stay on medication long-term because the benefit clearly outweighs the burden, and that’s a perfectly reasonable choice.